Moteur de recherche d’entreprises européennes

Financement de l’UE (14,9 M €) : Fournir des services de recherche sur le cancer de pointe dans toute l’Europe Hor01/09/2022 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Fournir des services de recherche sur le cancer de pointe dans toute l’Europe

canSERVs mission is to make cutting-edge and customised research services available to the cancer research community EU wide, enable innovative R&D projects and foster precision medicine for patients benefit across Europe. By connecting, coordinating, and aligning existing oncology and complimentary research infrastructures (RIs) and providing services in a synergistic way transnationally, canSERV will capitalise on the critical mass of experts and cutting-edge services offered by canSERVs RIs and their extended network. canSERV brings together world-class European life science RIs (BBMRI, EURO-BIOIMAGING, ELIXIR, EU-IBISBA, EuroPDX, EU-OPENSCREEN, INSTRUCT, EATRIS, INFRAFRONTIER, EMBRC, ECRIN, EATRIS, MIRRI, ARIE, CCE, EORTC and IARC) that collectively not only covers all aspects along the development pipeline for oncology, but is also capable of interconnecting these technologies providing users a guidance for navigating them through the entire translational value chain. A patient organisation or resp. governance board members will bring the patients perspective, while the PNO Innovation and PNO Life Sciences & Health will provide valuable input regarding stakeholder engagement, and project management activities. A common access management system (CAMS) will be developed based on mature solutions from INSTRUCT and BBMRI. The CAMS will provide a method for selection of services, construction and submission of research proposals, multi-step review of research proposals, and tracking of the access process from approval through delivery to conclusion. Through a united user-intuitive transnational access where a united catalogue of oncology services will be offered, our users will have access to a comprehensive service portfolio. As our ambition is to scale up canSERV to a pan-European collaboration of RIs for accelerating the development and implementation of solutions for the cancer patient community, the sustainability of this network beyond the end of the project will also be addressed.


The University of Manchester ?
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) 3 507 489 €
Centre International de Recherche sur le Cancer 313 255 €
Eatris Eric 1 517 325 €
Ecrin European Clinical Research Infrastructure Network 1 074 996 €
Euro-Bioimaging Eric 1 024 516 €
European Cancer Patient Coalition 0,00 €
European Infrastructure OF Open Screening Platforms FOR Chemical Biology European Research Infrastucture Consortium (EU-Openscreen Eric) 1 397 300 €
European Marine Biological Resource Centre European Research Infrastructure Consortium 116 846 €
European Molecular Biology Laboratory 426 946 €
Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio) 680 471 €
Infrafrontier Eric 1 104 988 €
Instruct-Eric 1 376 753 €
Organisation Europeenne Pour la Recherche et le Traitement du Cancer Aisbl 638 895 €
PNO Innovation GmbH 175 000 €
PNO Life Sciences & Health B.V. 160 000 €
Universidade do Minho 69 550 €
Universita Degli Studi Di Torino 791 290 €
Wageningen University 490 820 €

https://cordis.europa.eu/project/id/101058620

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : The University of Manchester, Manchester, Royaume Uni.